Alpha fetoprotein level, systemic inflammation response index, alanine aminotransferase, tumour diameter and portal vein tumour thrombus were also confirmed to be independent prognostic factors of HCC early recurrence in patients with MVI who underwent TACE(Mao et al. 2022). This evidence concerns the gene GPT and hepatocellular carcinoma.